Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer J. 2010 Mar-Apr;16(2):142-9. doi: 10.1097/PPO.0b013e3181d7ea51.

Implanted hepatic arterial infusion pumps.

Author information

1
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021-6007, USA. kemenyn@mskcc.org

Abstract

Globally, the number of colorectal carcinoma-related deaths totals close to 600,000 each year, with metastatic disease representing the major cause of morbidity and mortality. The liver is the most common site of metastasis for patients diagnosed with colorectal carcinoma. Although surgical resection is the mainstay for treatment with curative intent, this option is available to a minority of patients with metastatic disease. Hepatic arterial infusion chemotherapy was developed with the intention to focus treatment on a site of difficult to control metastatic disease. In this review, we aim to present the rationale for the development of hepatic arterial infusion chemotherapy, the basic anatomic and pharmacological underpinnings of this treatment, the associated toxicities, and a brief survey of the expanding applications for this approach.

PMID:
20404611
DOI:
10.1097/PPO.0b013e3181d7ea51
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center